Seeing Is Believing
Currently out of the existing stock ratings of Matthew Taylor, 124 are a BUY (59.62%), 68 are a HOLD (32.69%), 16 are a SELL (7.69%).
Analyst Matthew Taylor works at JEFFERIES with a stock forecast success ratio of 67.75% fulfilled within 155.82 days on average.
Matthew Taylor’s has documented 378 price targets and ratings displayed on 33 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MASI, Masimo at 30-Jan-2024.
Analyst best performing recommendations are on INMD (INMODE LTD).
The best stock recommendation documented was for TNDM (TANDEM DIABETES CARE) at 11/27/2018. The price target of $36 was fulfilled within 2 days with a profit of $2.71 (8.14%) receiving and performance score of 40.7.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
141
$27.52 (24.25%)
133
2 months 3 days ago
13/21 (61.9%)
$28.99 (25.88%)
291
Buy
126
$12.52 (11.03%)
130
2 months 4 days ago
7/14 (50%)
$13.55 (12.05%)
292
Buy
127
$13.52 (11.91%)
110
2 months 4 days ago
12/18 (66.67%)
$14.55 (12.94%)
190
Buy
125
$11.52 (10.15%)
125
2 months 5 days ago
6/7 (85.71%)
$14.23 (12.85%)
250
Buy
136
$22.52 (19.84%)
118
2 months 7 days ago
8/11 (72.73%)
$21.81 (19.10%)
253
Which stock is Matthew Taylor is most bullish on?
Which stock is Matthew Taylor is most reserved on?
What Year was the first public recommendation made by Matthew Taylor?